Ginkgo Bioworks Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Ginkgo Bioworks Holdings generated cash of -$295,500,000, which is less than the previous year. Cash used in financing activities reached the amount of -$3,216,000 last year. Net change in cash is therefore -$379,997,000.
Cash Flow
| 2019 | -44.66M | -74.60M | 410.38M |
|---|---|---|---|
| 2020 | -135.83M | -67.12M | 90.31M |
| 2021 | -253.81M | -73.25M | 1.53B |
| 2022 | -252.19M | -67.39M | 95.33M |
| 2023 | -295.5M | -80.69M | -3.21M |
DNA Cash Flow Statement (2019 â 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 1.36B | 1.59B | 385.87M | 498.51M | 207.39M |
Operating activities | |||||
Net income | -892.86M | -2.10B | -1.83B | -126.72M | -119.85M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 71.55M | 44.42M | 29.07M | 13.86M | 10.75M |
Stock-based compensation expense | 229.88M | 1.93B | 1.60B | 476K | 771K |
| Deferred income tax benefit | 229.88M | 1.93B | 1.60B | 476K | 771K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 50.06M | 55.02M | -114.09M | -14.22M | -1.84M |
Inventories | 0 | 164K | -626K | -2.73M | -2.22M |
Accounts payable | -1.18M | -10.84M | -2.24M | 7.01M | 664K |
Cash generated by operating activities | -295.5M | -252.19M | -253.81M | -135.83M | -44.66M |
Investing activities | |||||
Purchases Of Investments | 0 | -3.69M | -5M | 0 | -50.13M |
Investments In Property Plant And Equipment | -40.80M | -52.27M | -56.52M | -57.82M | -22.21M |
Acquisitions Net | -38.55M | 26.64M | -12.04M | 0 | 0 |
Cash generated by investing activities | -80.69M | -67.39M | -73.25M | -67.12M | -74.60M |
Financing activities | |||||
Common Stock Issued | 0 | 99.30M | 1.50B | 91.06M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -23K | 0 | -24.99M | 0 | -408K |
Repayments of term debt | -1.29M | -1.23M | -1.12M | -748K | 198.60M |
Cash used in financing activities | -3.21M | 95.33M | 1.53B | 90.31M | 410.38M |
Net Change In Cash | -379.99M | -223.34M | 1.20B | -112.63M | 291.12M |
Cash at end of period | 989.58M | 1.36B | 1.59B | 385.87M | 498.51M |
| Data source | Data source | Data source |